Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Cardinal Health’s Debbie Weitzman and Value Drug Company’s Rick Seipp to lead HDA board

Summary by CDR – Chain Drug Review
“Debbie and Rick bring deep industry experience and a strong understanding of the issues facing pharmaceutical distributors today,” said Chester “Chip” Davis, Jr., HDA president and chief executive officer.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

CDR – Chain Drug ReviewCDR – Chain Drug Review

Cardinal Health’s Debbie Weitzman and Value Drug Company’s Rick Seipp to lead HDA board

“Debbie and Rick bring deep industry experience and a strong understanding of the issues facing pharmaceutical distributors today,” said Chester “Chip” Davis, Jr., HDA president and chief executive officer.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

CDR – Chain Drug Review broke the news on Monday, September 14, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Dublin, Ohio icon

Dublin, Ohio

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal